E-LIB Suche - Ergebnisse für: Jaehnig, Peter

1

Correction to: LHRH sparing therapy in patients with chemot..:

Ohlmann, Carsten-Henning ; Jäschke, Michelle ; Jaehnig, Peter...
Prostate Cancer and Prostatic Diseases. 26 (2023) 4 - p. 812-812 , 2023

Link: https://doi.org/10.1038/..

2

LHRH sparing therapy in patients with chemotherapy-naïve, m..:

Ohlmann, Carsten-Henning ; Jäschke, Michelle ; Jaehnig, Peter...
Prostate Cancer and Prostatic Diseases. 25 (2022) 4 - p. 778-784 , 2022

Link: https://doi.org/10.1038/..

3

Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–D..:

Frey, Sharon E ; Shakib, Sepehr ; Chanthavanich, Pornthep...
Open Forum Infectious Diseases. 6 (2019) 4 - p. , 2019

Link: https://doi.org/10.1093/..

4

VicTORia: a randomised phase II study to compare vinorelbin..:

Decker, Thomas ; Marschner, Norbert ; Muendlein, Axel...
Breast Cancer Research and Treatment. 176 (2019) 3 - p. 637-647 , 2019

Link: https://doi.org/10.1007/..

5

Abiraterone acetate plus LHRH therapy versus abiraterone ac..:

Ohlmann, Carsten-Henning ; Jäschke, Michelle ; Jaehnig, Peter...
Trials. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

6

Safety and tolerability of a cell culture derived trivalent..:

Nolan, Terry ; Chotpitayasunondh, Tawee ; Capeding, Maria Rosario...
Vaccine. 34 (2016) 2 - p. 230-236 , 2016

Link: https://doi.org/10.1016/..

7

Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Va..:

Johnson, Casey ; Hohenboken, Matthew ; Poling, Terry..
The Journal of Infectious Diseases. 212 (2015) 1 - p. 72-80 , 2015

Link: http://www.jstor.org/sta..

8

Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Va..:

Johnson, Casey ; Hohenboken, Matthew ; Poling, Terry..
The Journal of Infectious Diseases. 212 (2014) 1 - p. 72-80 , 2014

Link: https://doi.org/10.1093/..

9

Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro..:

Rose, Sarah ; Nomoto, Masahiro ; Jackson, E.Amanda...
European Journal of Pharmacology. 230 (1993) 2 - p. 177-185 , 1993

Link: https://doi.org/10.1016/..

10

Motor activity following the administration of selective D-..:

Löschmann, Peter-A. ; Smith, Lance A. ; Lange, Klaus W....
Psychopharmacology. 105 (1991) 3 - p. 303-309 , 1991

Link: https://doi.org/10.1007/..

11

Correction to: LHRH sparing therapy in patients with chemot..:

Ohlmann, Carsten-Henning ; Jäschke, Michelle ; Jaehnig, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638078/. , 2023

Link: http://www.ncbi.nlm.nih...

12

LHRH sparing therapy in patients with chemotherapy-naïve, m..:

Ohlmann, Carsten-Henning ; Jäschke, Michelle ; Jaehnig, Peter...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705242/. , 2022

Link: http://www.ncbi.nlm.nih...

13

LHRH sparing therapy in patients with chemotherapy-naïve, m..:

Ohlmann, Carsten-Henning ; Jäschke, Michelle ; Jaehnig, Peter...
https://static-content.springer.com/esm/art%3A10.1038%2Fs41391-022-00533-6/MediaObjects/41391_2022_533_MOESM1_ESM.docx. , 2022

Link: http://nbn-resolving.org..

14

Abiraterone acetate plus LHRH therapy versus abiraterone ac..:

Carsten-Henning Ohlmann ; Michelle Jäschke ; Peter Jaehnig...
http://link.springer.com/article/10.1186/s13063-017-2195-x. , 2017

Link: https://doi.org/10.1186/..

15

Optical modeling for the LiteBIRD Medium and High Frequency..:

Lamagna, Luca ; Franceschet, Cristian ; De Petris, Marco...
https://orbi.uliege.be/handle/2268/296953. , 2022

Link: https://orbi.uliege.be/h..